News & Events about Ideaya Biosciences Inc.
IDEAYA Announces Pricing of Public Offering IDEAYA Announces Pricing of Public Offering PR Newswire SOUTH SAN FRANCISCO, Calif., April 24, 2023 SOUTH SAN FRANCISCO, Calif., April 24, 2023 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq:IDYA) today announced the pricing of an underwritten public...
IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib Combination and Successful FDA Type C Meeting on Registrational Trial Design for Accelerated Approval in First-Line Metastatic Uveal Melanoma IDEAYA Announces Positive Interim Phase 2 Data for Darovasertib and Crizotinib...
IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) PR Newswire SOUTH SAN FRANCISCO, Calif., March 31, 2023 SOUTH SAN FRANCISCO, Calif., March 31, 2023 /PRNewswire/ -- IDEAYA...
Ticker Report
4 months ago
IDEAYA Biosciences, Inc. (NASDAQ:IDYA Get Rating) Stock analysts at Capital One Financial issued their FY2027 EPS estimates for shares of IDEAYA Biosciences in a report issued on Tuesday, January 24th. Capital One Financial analyst Z. Jallah forecasts that the company will earn $1.90...